aTyr Pharma ATYR Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $10.01M-3.4% | $10.74M-2.8% | $6.15M-46.3% | $17.22M+153% | $10.36M+52.2% | ||
| $56.51M-14.4% | $67.94M+11.3% | $84.05M+54.1% | $63.13M-11.9% | $65.99M-15.1% | ||
| $67.58M-18.8% | $80.24M-2.1% | $93.01M+21.9% | $87.49M-3.1% | $83.27M-14.1% | ||
| $4.24M-9.5% | $4.26M-12.1% | $4.43M-11.8% | $4.53M-12.7% | $4.68M-12.5% | ||
| $79.65M-18.1% | $93M-4.0% | $106.65M+16.4% | $101.53M-4.2% | $97.25M-14.1% | ||
| $2.76M+79.9% | $3.89M-10.0% | $4.06M+2.9% | $3.88M+209% | $1.53M-68.7% | ||
| $596K+8.4% | $630K+16.5% | $630K+19.3% | $562K+8.7% | $550K+8.5% | ||
| $11.7M+9.5% | $15.15M+1.2% | $15.68M+11.0% | $15.53M+31.2% | $10.68M-33.1% | ||
| $98K+10.1% | $98K+16.7% | $98K+28.9% | $93K+22.4% | $89K+30.9% | ||
| -$616.96M-12.8% | -$606.16M-13.9% | -$592.2M-14.5% | -$566.46M-13.3% | -$546.93M-13.1% | ||
| $57.93M-22.8% | $67.48M-3.6% | $80.24M+22.8% | $74.85M-8.3% | $75.05M-11.1% | ||
| $79.65M-18.1% | $93M-4.0% | $106.65M+16.4% | $101.53M-4.2% | $97.25M-14.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are aTyr Pharma's total assets?
- aTyr Pharma (ATYR) holds $79.7M in total assets, down 18.1% year over year.
- How much debt does aTyr Pharma have?
- aTyr Pharma carries $12.3M in total debt against $57.9M of shareholders' equity, a debt-to-equity ratio of 0.21.
- How much cash does aTyr Pharma have?
- aTyr Pharma holds $10.0M in cash and equivalents.
- Can aTyr Pharma cover its short-term obligations?
- Its current ratio is 5.78 — current assets exceed current liabilities.
- Where does aTyr Pharma's balance sheet data come from?
- Every line is extracted from aTyr Pharma's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
